IL6 and type 2 diabetes mellitus: IL-6 acts as a marker of chronic inflammation in T2D, and its elevation is linked to dysbiosis, reinforcing the need to better understand its role and potential strategies to modulate its signaling in the treatment of this disease [28,31].